Insider at

04

Insider transactions

05
0 buys (P) 1 sells (S) Net: $-399,250 + 74 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

74 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Dec. 15, 2025 NPCE S 10b5-1 25,000 $15.97 $399,250 49,964 Direct -33.35% Disposed -20.5% (price as of 2026-10-02)
Feb. 21, 2025 NPCE S 10b5-1 78,334 $13.72 $1,074,742 81,993 Direct -48.86% Disposed -7.4% (price as of 2026-10-02)
Jan. 30, 2025 NPCE S 10b5-1 200 $15.00 $3,000 86,762 Direct -0.23% Disposed -15.3% (price as of 2026-10-02)
Jan. 29, 2025 NPCE S 10b5-1 100 $15.00 $1,500 86,962 Direct -0.11% Disposed -15.3% (price as of 2026-10-02)
Jan. 24, 2025 NPCE S 10b5-1 3,200 $15.01 $48,032 87,062 Direct -3.55% Disposed -15.4% (price as of 2026-10-02)
Feb. 5, 2024 NPCE S 10b5-1 3,446 $15.17 $52,276 77,762 Direct -4.24% Disposed -16.3% (price as of 2026-10-02)
Feb. 2, 2024 NPCE S 10b5-1 14,143 $15.07 $213,135 81,208 Direct -14.83% Disposed -15.7% (price as of 2026-10-02)
Feb. 1, 2024 NPCE S 10b5-1 663 $15.04 $9,972 95,351 Direct -0.69% Disposed -15.6% (price as of 2026-10-02)
Jan. 31, 2024 NPCE S 10b5-1 1,923 $15.08 $28,999 96,014 Direct -1.96% Disposed -15.8% (price as of 2026-10-02)
Jan. 30, 2024 NPCE S 10b5-1 11,262 $15.10 $170,056 97,937 Direct -10.31% Disposed -15.9% (price as of 2026-10-02)
Jan. 25, 2024 NPCE S 10b5-1 1 $15.00 $15 109,199 Direct 0.00% Disposed -15.3% (price as of 2026-10-02)
Jan. 24, 2024 NPCE S 10b5-1 827 $15.02 $12,422 109,200 Direct -0.75% Disposed -15.4% (price as of 2026-10-02)
Dec. 27, 2023 NPCE S 10b5-1 13,300 $10.12 $134,596 110,027 Direct -10.78% Disposed 25.5% (price as of 2026-10-02)
Dec. 26, 2023 NPCE S 10b5-1 102 $10.00 $1,020 123,327 Direct -0.08% Disposed 27.0% (price as of 2026-10-02)
Dec. 20, 2023 NPCE S 10b5-1 2,730 $10.14 $27,682 123,429 Direct -2.16% Disposed 25.2% (price as of 2026-10-02)
Dec. 6, 2023 NPCE S 10b5-1 11,005 $8.16 $89,801 126,159 Direct -8.02% Disposed 55.6% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
May 15, 2026 NPCE Stock Option (Right to Buy) Common Stock (14,550) $15.36 May 14, 2036 14,550 Acquired
March 24, 2025 NPCE Stock Option (Right to Buy) Common Stock (19,850) $12.30 March 23, 2035 19,850 Acquired
Feb. 27, 2024 NPCE Stock Option (Right to Buy) Common Stock (24,950) $17.11 Feb. 26, 2034 24,950 Acquired
Feb. 12, 2024 NPCE Stock Option (Rt to Buy) Common Stock (50,000) $0.03 Oct. 29, 2030 50,000 Disposed
Jan. 31, 2024 NPCE Stock Option (Rt to Buy) Common Stock [F2] (192) $0.03 Nov. 30, 2030 192 Disposed
Jan. 31, 2024 NPCE Stock Option (Rt to Buy) Common Stock (192) $0.03 Nov. 30, 2030 192 Disposed
Jan. 31, 2024 NPCE Stock Option (Rt to Buy) Common Stock (192) $0.03 Nov. 30, 2030 192 Disposed
Jan. 31, 2024 NPCE Stock Option (Rt to Buy) Common Stock (12,234) $0.03 Nov. 30, 2030 12,234 Disposed
Jan. 31, 2024 NPCE Stock Option (Rt to Buy) Common Stock (40,000) $0.03 Nov. 30, 2030 40,000 Disposed
Oct. 7, 2022 NPCE Stock Option (Right to Buy) Common Stock (384) $0.03 March 8, 2023 384 Disposed
Oct. 7, 2022 NPCE Stock Option (Right to Buy) Common Stock (192) $0.03 Nov. 13, 2022 192 Disposed
March 3, 2022 NPCE Stock Option (Right to Buy) Common Stock (93,530) $8.15 March 2, 2032 93,530 Acquired
June 4, 2021 NPCE Stock Option (Right to Buy) Common Stock (16,620) $21.67 June 3, 2031 16,620 Acquired
June 4, 2021 NPCE Stock Option (Right to Buy) Common Stock (16,363) $21.67 June 3, 2031 16,363 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 9 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
April 20, 2021 NPCE Common Stock 1,518 Direct
April 20, 2021 NPCE Stock Option (Right to Buy)→ Common Stock (278,846) 278,846 Direct
April 20, 2021 NPCE Stock Option (Right to Buy)→ Common Stock (192) 192 Direct
April 20, 2021 NPCE Stock Option (Right to Buy)→ Common Stock (192) 192 Direct
April 20, 2021 NPCE Stock Option (Right to Buy)→ Common Stock (192) 192 Direct
April 20, 2021 NPCE Stock Option (Right to Buy)→ Common Stock (384) 384 Direct
April 20, 2021 NPCE Stock Option (Right to Buy)→ Common Stock (12,234) 12,234 Direct
April 20, 2021 NPCE Stock Option (Right to Buy)→ Common Stock (192) 192 Direct
April 20, 2021 NPCE Stock Option (Right to Buy)→ Common Stock (192) 192 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

NPCE

M.D.Chief Medical Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2025 $489,842 · $140,634 $168,183 $235,473 · · $1,034,132
2024 $486,702 · $213,875 $287,514 $181,460 · · $1,169,551
2023 $468,502 · $380,000 · $260,174 · · $1,108,676

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.